Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial
Toshihiko Doi, Yukinori Kurokawa, Akira Sawaki, Yoshito Komatsu, Masato Ozaka, Tsuyoshi Takahashi, Yoichi Naito, Shuichi Ohkubo, Toshirou Nishida
研究成果: Article › 査読
28
被引用数
(Scopus)